Biointron has established an industry-leading 2-week antibody production service, supported by a powerful high-throughput expression platform. Armed with this high-efficiency platform, our FC-MES affinity maturation system is capable of providing non-biased antibody optimization and affinity maturation in less than 2 months. Additionally, our VHH and single B-cell-based discovery projects benefit significantly and are expedited by this unique capability.

Lei Shi, PhD. is Senior Vice President of Biointron. He has more than 20 years of experience in antibody discovery. Previously Lei worked for a number of pharmaceutical and biotech companies such as Johnson & Johnson with increasing responsibilities, He completed his postdoc research at MGH and Harvard Medical School and has an Executive Masters degree from University of Pennsylvania.
July
16th, 2024 | 10:30 AM GMT+8
Virtual
| Register Here
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



